LC-1 is a solid phase enzyme immunoassay employing human recombinant formiminotransferase-cyclodeaminase (cytosolic liver antigen) for the quantitative detection of anti-liver cytosol type 1 autoantibodies (anti-LC-1) in human serum. The assay is a tool for the diagnosis of autoimmune hepatitis (AIH).
LKM-1 is a solid phase enzyme immunoassay employing human recombinant cytochrome p450 IID6 for the quantitative detection of antibodies against liver-kidney microsomes (LKM) in human serum.
SLA/LP is a solid phase enzyme immunoassay employing human recombinant SLA/LP for the quantitative detection of IgG antibodies against soluble liver antigen (SLA) in human serum. The assay is a tool for the diagnosis of autoimmune hepatitis (AIH).
AMA-M2-G is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).
AMA-M2-M is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgM antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).
AMA-M2-Check is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG and IgM antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).